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Abstract
 
Depending on the duration and severity, psychological tension and physical stress can enhance
or suppress the immune system in both humans and animals. Although it is well established that
stress alters the release of various hormones and neurotransmitters, the mechanisms by which
stress affects immune responses remain elusive. We report here that mice subjected to chronic
12-hour daily physical restraint for two days exhibited a significant reduction in splenocytes, a
process likely mediated by apoptosis as demonstrated by the terminal deoxynucleotidyl trans-
ferase–mediated deoxyuridine triphosphate nick end labeling assay. CD95 (Fas/APO-1) expres-
sion in splenic lymphocytes of stressed mice was substantially increased. Interestingly, Fas-immu-
noglobulin fusion protein and blocking antibodies against CD95 ligand inhibit stress-induced
reduction in lymphocytes. The stress-induced changes in CD95 expression and lymphocyte
number could be blocked by naltrexone or naloxone, specific opioid receptor antagonists, indi-
cating a pivotal role of endogenous opioids in this process. In addition, the reduction of spleno-
cytes in this model system seems to be independent of the hypothalamo-pituitary-adrenal axis,
as both adrenalectomized and sham-operated  mice exhibited similar responses to chronic
stress. Moreover, chronic physical restraint failed to induce a decrease in lymphocyte numbers
in CD95-deficient (Fas
 
lpr/lpr
 
) mice. Therefore, stress modulates the immune system through
CD95-mediated apoptosis dependent on endogenous opioids.
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Introduction
 
Bidirectional interactions between the immune and neu-
roendocrine systems influence antibody and cytokine re-
sponses (1, 2), cytolytic activity, lymphocyte proliferation
(3), tissue localization and number of lymphocytes (4, 5),
hypothalamic-pituitary hormone secretion (6), and neural
signal transmission (7–9). These interactions are likely in-
volved in the maintenance of cellular homeostasis in several
systems, which is best exemplified in response to stress. Re-
cent progress in psychoneuroimmunology has revealed that
stress could either suppress or enhance immune responses
depending on the type and duration of the stressors (10–
13). Numerous studies have revealed that exhausting phys-
ical activity and severe environmental and/or psychological
stress have strong suppressive effects on the immune system
(14). Such suppression of the immune system has signifi-
cant implications for disease susceptibility and progression.
Investigations in both humans and animals have revealed
that stress could promote tumor development (15, 16), au-
toimmunity (17), and infectious diseases by influencing the
onset, course, and outcome of the pathological processes
(18, 19). Interestingly, acute psychological stressors and
moderate physical exercise transiently enhance immune re-
sponses (10, 11, 20–23). In a rodent model, Dhabhar and
McEwen (13) recently demonstrated that acute restraint
stress (2 h) could dramatically enhance delayed-type hyper-
sensitivity reaction. In addition, acute stress has also been
shown to increase antibody production (24). Though vari-
ous changes in the immune system have been shown to be
associated with stress, the exact mechanisms responsible for
stress-modulated immune response remain to be eluci-
dated.
CD95 (also known as Apo-1 or Fas), a transmembrane
protein belonging to the tumor necrosis factor/nerve
 
Address correspondence to Yufang Shi, Department of Immunology, Jer-
ome H. Holland Laboratory, American Red Cross, 15601 Crabbs Branch
Way, Rockville, MD 20855. Phone: 301-517-0392; Fax: 301-517-0344;
E-mail: shiy@usa.redcross.org 
1424
 
Stress Promotes Lymphocyte Apoptosis via CD95
 
growth factor receptor family of cell surface molecules, is
expressed on a variety of cell types including lymphocytes,
hepatocytes, ovarian epithelial cells, and some tumor cells
(25). Ligation of this molecule with specific agonistic anti-
bodies or its cognate ligand (CD95L) induces the activation
of a cascade of caspases and ultimately nucleases that result
in apoptotic cell death in many cell lineages (26, 27). CD95
was initially identified in the immune system, and has been
shown to mediate receptor-dependent programmed cell
death. Although the importance of Fas–FasL interactions is
not limited to the immune system, it is there that most of
the functional studies of Fas–FasL have originated. It is well
documented that activation-induced apoptosis in peripheral
T cells and T cell hybridomas is mediated through Fas–
FasL interaction and is believed to serve as a guard against
autoimmunity (26, 28, 29). Mice and humans with muta-
tions in CD95 or CD95L develop lymphocyte accumula-
tion disease (30). Thus, the CD95–CD95L system plays an
integral role in maintaining cellular homeostasis of the im-
mune system and may contribute to the alteration of the
immune system under chronic stress.
Stress induces the production of various hormones and
neural peptides (22, 31). Corticosteroids and endogenous
opioids are the best-recognized mediators modulating the
immune response. It is well established that corticosteroid
plays a critical role under stress conditions (32). Cortico-
steroid enhances immune response during acute stress (13,
21) and suppresses the immune response during chronic
stress (13). On the other hand, endogenous opiate peptides
are known to be elevated by both acute and chronic stress,
and play a critical role in regulating behavioral and emo-
tional stress–induced changes of the immune system (33).
These peptides could induce the production of corticoste-
roid via the hypothalamo-pituitary-adrenal (HPA) axis (34).
Three highly conserved opioid receptors have been identi-
fied, all of which have been found on lymphocytes (35).
Blockade of endogenous opioids with naloxone has been
demonstrated to attenuate or reverse stress-induced eleva-
tion in blood pressure. Recent studies have revealed that
excessive production of endogenous opioids under situa-
tions of chronic stress is associated with the suppression of
the immune system (36). Because exogenous opioid recep-
tor agonists such as morphine induce a reduction in the
number of lymphocytes by modulating CD95 expression
(37), we examined the role of CD95 in the modulation of
the immune system by chronic stress. We show in this
study that chronic 12-h daily physical restraint for 2 d pro-
motes CD95 expression dependent on endogenous opioid,
and that the subsequent induction of apoptosis through
CD95 plays a central role in stress-induced reduction of
lymphocytes.
 
Materials and Methods
 
Physical Restraint.
 
7–9-wk-old mice were subjected to an es-
tablished chronic physical restraint protocol (19). They were
placed in a 50-ml conical centrifuge tube filled with multiple
punctures to allow ventilation. Mice were held horizontally in
the tubes for a continuous 12 h followed by a 12-h rest, while
food and water were provided ad libitum. The control littermates
were kept in their original cage, but food and water were pro-
vided only during the stress interval of the experimental groups.
Mice were physically restrained for one to three cycles as speci-
fied. This physical restraint procedure was approved by the Insti-
tutional Animal Care and Use Committee of the Holland Labo-
ratory of the American Red Cross.
 
Analysis of CD95 Expression.
 
Total RNA was isolated from
spleens by TriPure™ Isolation Reagent (Boehringer Mannheim)
according to a protocol recommended by the manufacturer.
RNA samples were fractionated on 1% agarose/2.2 M formalde-
hyde denaturing gel and transferred onto Nytran
 
®
 
 membrane
(Schleicher & Schuell). The cDNA probes (CD95 and glyceral-
dehyde-3-phosphate dehydrogenase [GAPDH]) were labeled
with 
 
32
 
P-dCTP by random priming method (Boehringer Mann-
heim) according to the manufacturer’s instructions. Hybridization
signals were detected by autoradiography.
 
DNA Fragmentation.
 
Nucleosomal DNA fragmentation in
spleens was determined by the terminal deoxynucleotidyl trans-
ferase–mediated deoxyuridine triphosphate nick end labeling
(TUNEL) assay using an in situ apoptosis detection kit (Trevigen)
according to the manufacturer’s instructions. The 3
 
9
 
-OH ends of
fragmented nucleosomal DNA were specifically labeled in situ in
the presence of exogenously added terminal transferase and fluo-
rescence-labeled dNTP, and were detected with anti-fluorescein
antibody peroxidase conjugate.
Genomic DNA integrity was also analyzed by DNA content
in the nuclei. Cells were fixed with 70% ethanol for 30 min at
4
 
8
 
C, then washed twice with PBS. The fixed cells were then in-
cubated in PBS containing propidium iodide (Sigma Chemical
Co.) at 50 
 
m
 
g/ml and RNaseA (Boehringer Mannheim) at 0.1
mg/ml at room temperature for 30 min. DNA content was de-
termined by flow cytometry, and the FL2 intensity was plotted as
a histogram on a linear scale.
 
Induction of Apoptosis by CD95 Ligation.
 
Single cell suspen-
sions of murine splenocytes were prepared by gently squeezing
the spleen between frosted glass microscope slides. Red blood
cells were lysed with buffered 1% ammonium chloride. Spleno-
cytes cells were then cocultured with L cells expressing sense or
antisense CD95L (provided by Dr. T.A. Ferguson, Washington
University School of Medicine, St. Louis, MO). Apoptosis in
nonadherent cells was determined at 24 h by flow cytometric
DNA content analysis.
 
Adrenalectomy.
 
Bilateral
 
 
 
adrenalectomy
 
 
 
was performed on
10-wk-old Balb/c mice. Mice were anesthetized by intraperito-
neal injection of ketamine (90 mg/kg) plus xylazine (10 mg/kg).
A 0.5-cm skin incision was made on the back. The skin on both
sides of the incision was side moved, and a muscle incision was
made on the top of each adrenal gland. The entire adrenal gland
was removed with a pair of heated fine forceps. The skin incision
was closed with a surgical clip. After recovery, the mice were
maintained by providing food, water, and sodium chloride block
ad libitum. Control animals (sham group) underwent the same
surgical procedure as the adrenalectomized animals, except their
adrenal glands were not removed. Experiments were performed
with these mice at 2–3 wk after adrenalectomy.
 
Results and Discussion
 
We subjected BALB/c mice aged 7–9 wk to a 12-h
physical restraint regimen daily for 2 d (19, 38) and found 
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that this treatment dramatically affected splenic cellularity.
These mice showed 35–40% reduction in their number of
lymphocytes in the spleen compared with unstressed con-
trols (Fig. 1 A). Since it is well established that overproduc-
tion of endogenous opioids could dramatically affect the
immune system, we employed naloxone or naltrexone as
specific antagonists of opioid receptors to determine the
role of endogenous opioids in the reduction of splenic lym-
phocytes in this chronic stress model. Although treatment
of mice with opioid antagonists (single intraperitoneal in-
jection 1 h before the initiation of each stress cycle) did not
alter the number of splenocytes in unstressed mice, admin-
istration of naltrexone (Fig. 1 A, experiment [Exp.] 1) or
naloxone (data not shown) before physical restraint com-
pletely blocked stress-induced reduction in splenocyte
numbers. Therefore, chronic physical restraint–induced
lymphocyte reduction appears to require endogenous opi-
oids.
We recently reported that exogenous opioids could in-
duce CD95 expression and promote CD95L-induced ap-
optosis in lymphocytes in both in vitro culture and in vivo
administration to mice (37). To verify the role of CD95 in
chronic stress–induced lymphocyte reduction, we injected
mice with serum from SCID mice bearing either 3T3 fibro-
sarcoma engineered to secrete Fas-Ig fusion protein (39) or
nonengineered 3T3 fibrosarcoma. Fas-Ig–containing serum
blocked chronic restraint stress–induced reduction in sple-
nocytes (Fig. 1 A, Exp. 2), whereas normal mouse serum
did not exhibit such an effect (data not shown). When the
Fas-Ig–containing serum was adsorbed with protein A
sepharose beads, its protective effect was eliminated (data
not shown). In addition, the Fas-Ig serum did not change
the number of splenocytes in unstressed mice. We also
found that a blocking antibody to CD95L (MFL3) but not
the isotype control also blocked stress-induced reduction in
lymphocyte numbers (Fig. 1 A, Exp. 3). Hence, the inter-
action between CD95 and CD95L is critical for chronic
stress–induced reduction of lymphocytes.
We next examined the level of CD95 in splenocytes
with or without physical restraint. As shown in Fig. 1 B,
the expression of CD95 in splenocytes was significantly en-
hanced at 12 h after physical restraint as detected by North-
ern blot analysis. Stress did not induce the expression of
CD95L (data not shown). Naltrexone inhibited this stress-
induced increase in CD95 expression. Interestingly, though
MFL3 prevented stress-induced reduction in lymphocytes,
it did not affect stress-induced CD95 expression (Fig. 1 B).
The effect of stress on CD95 expression was also observed
when detected by surface staining (data not shown). These
results suggest a prominent role of endogenous opioids in
the induction of CD95 expression.
The reduction of splenocytes induced by stress could be
mediated by two possible mechanisms: emigration or cell
death. First, we assessed cell death in histological sections of
spleens using a TUNEL technique. We found that a signif-
icant number of cells in the spleen of stressed mice were
undergoing apoptosis, whereas only a few apoptotic cells
were detected in the spleen of control mice (Fig. 2 A).
Thus, physical restraint–induced reduction in splenocyte
numbers is likely due to the induction of apoptosis rather
than the mobilization of lymphocytes. An effect of block-
ing CD95L with MFL3 (anti-FasL) on apoptosis was also
observed when examined by TUNEL (Fig. 2 A). There-
fore, stress-induced CD95 expression appears responsible
for the lymphocyte loss.
To examine whether stress-induced CD95 expression
modulates the sensitivity of lymphocytes to CD95L-medi-
ated apoptosis, we isolated splenocytes at the end of the 12-h
physical restraint and cocultured with adherent L cells
transfected with either sense or antisense CD95L cDNA for
24 h. Splenocytes in suspension were harvested, and cell vi-
ability was analyzed by cellular DNA content analysis. As
shown in
 
 
 
Fig. 2 B, splenocytes from chronically stressed
mice underwent apoptosis as indicated by the appearance
of a hypodiploid peak upon incubation with L cells ex-
pressing sense CD95L, whereas control cells showed only
minimal apoptosis. This stress-induced CD95-mediated ap-
optosis is specific, as cells from stressed mice did not un-
dergo apoptosis when cocultured with L cells transfected
Figure 1. Physical restraint–induced lymphocyte reduction in the
spleen requires opioid receptors and CD95–CD95L interaction. (A)
Balb/c mice aged 7–9 wk were subjected to a 12-h physical restraint
daily for 2 d. The following reagents were administered immediately be-
fore physical restraint in position: naltrexone (single intraperitoneal in-
jection of 200 mg in PBS at 1 h before the initiation of each stress cycle),
Fas-Ig (100 mg per mouse in PBS), and MFL3 (Anti-FasL; 10 mg per
mouse in PBS). Mice were killed by CO2 asphyxiation, and total spleno-
cytes were enumerated. Means and SEs were calculated from 5–10 mice
per group. (B) Stress induces the expression of CD95. Balb/c mice at 7
wk of age were stressed for 12 h with or without anti–mouse FasL (10
mg per mouse) or naltrexone (200 mg per mouse) for 12 h. Total RNA
was isolated from splenocytes and analyzed for CD95 expression by
Northern blot hybridization with cDNA probe for CD95. GAPDH pro-
vides a control for RNA loading. 
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with antisense CD95L cDNA. Thus, chronic stress–induced
CD95 expression could promote CD95L-induced apop-
tosis.
Loss-of-function mutations in CD95 reduce apoptosis
and cause the development of lymphocyte accumulation
diseases in both humans and mice (27). To further investi-
gate the role of CD95 in chronic physical restraint stress–
induced reduction in lymphocyte numbers, we subjected
mice bearing autosomal recessive mutations in CD95
(C3H.MRL.Fas
 
lpr/lpr
 
) and their appropriate background
control, C3H/HeJ, to physical restraint. Stress-induced re-
duction in the numbers of splenocytes was observed in
C3H/HeJ but not in C3H.MRL.Fas
 
lpr/lpr
 
 mice (Fig. 3).
Therefore, mice with a loss-of-function mutation of CD95
lose their sensitivity to stress-induced reduction in lympho-
cyte numbers, further supporting the conspicuous role of
CD95 for the stress response.
The blockade of chronic stress–induced lymphocyte re-
duction by opioid antagonists (Fig. 1 A) strongly suggests a
pivotal role of endogenous opioids in this process. As it has
been shown that opioids could exert their effects by modu-
lating the production of corticosteroid via the HPA axis
(34), we performed chronic restraint stress in adrenalecto-
mized mice. We have found that adrenalectomy did not
significantly affect the stress-induced reduction in spleno-
cytes (Fig. 4). Therefore, the HPA axis is unlikely to be in-
Figure 2. Physical restraint induces apop-
totic cell death. (A)  Balb/c 7–9-wk-old
mice were subjected to a 12-h physical re-
straint daily for 2 d with or without anti–
mouse FasL (10 mg per mouse) or naltrex-
one (200 mg per mouse). TUNEL-positive
apoptotic cells in frozen spleen sections
were shown in dark brown on a methyl
green counterstained background. (B)
Stress primes lymphocytes to CD95L-medi-
ated apoptosis. Splenocytes from mice
stressed for 12 h or from unstressed mice
were cocultured with L cells transfected
with CD95L cDNA in sense (S) or anti-
sense (AS) orientations. Nonadherent cells
were harvested at 24 h. DNA content was
analyzed by flow cytometry after staining
with propidium iodide. 
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volved in mediating the reduction of splenocytes in this
chronic restraint stress model. Our finding of the absence
of an effect of adrenalectomy on chronic stress–induced
splenocyte reduction is in contrast with the demonstration
of the role of the adrenal gland in acute stress–induced en-
hancement of delayed-type hypersensitivity response (21).
This discrepancy is likely to be due to the stress duration
and the evaluation parameters. Indeed, McEwen et al. (22)
have suggested that the spleen is a relatively privileged site
and is relatively inaccessible to endogenously produced
corticosteroids. Therefore, our observation of the dispens-
ability of adrenal glands in chronic stress–induced spleno-
cyte reduction strongly suggests that the effects of endoge-
nous opioids are likely exerted directly on splenocytes. This
agrees with our previous finding that opioids induce the
expression of Fas and sensitize cells to FasL-mediated apop-
tosis in cultured lymphocytes (37).
CD95 and its cognate ligand, CD95L, play a critical role
in the regulation of cellular homeostasis, especially in the
immune system. Loss-of-function mutations in the CD95
(
 
lpr
 
) and CD95L (
 
gld
 
) genes are characterized by excessive
lymphoproliferation with accelerated autoimmune disor-
ders (14). In addition, the interaction between CD95 and
CD95L has also been shown to be important in maintain-
ing immune-privileged sites such as Sertoli cells of the tes-
tis, the corneal epithelium, and the retina of the eye (27,
28). Interestingly, some tumors also express FasL, and this
has been suggested as a mechanism to escape immune sur-
veillance. Our finding of the role of CD95 in chronic
stress–induced lymphocyte reduction reveals another im-
portant function of this molecule.
Stress affects our daily life. It is clear that moderate stress
such as routine exercise could enhance immune response
(11, 13). However, chronic stress such as long-term emo-
tional stress can decrease immune function and increase
disease susceptibility. Our demonstration of a central role
for endogenous opioids and its link to cell death receptor
CD95 expression in response to chronic restraint stress is of
particular interest. We believe that identification of the
specific opioid peptides and opioid receptor types involved
in this process will provide biochemical understanding of
the mechanisms by which the neuronal and the immune
system communicate.
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